Blog
RSS FeedPosted by Michael Wonder on 01 Dec 2021
PHARMAC in review (2021)
2 December 2021 - Another dismal year in terms of the number of new medicines listed in the New Zealand ...
Posted by Michael Wonder on 30 Nov 2021
New Zealand Pharmaceutical Schedule - 1 December 2021
1 December 2021 - The December 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 25 Nov 2021
PHARMAC publishes minutes of August 2021 PTAC meeting
25 November 2021 - Another sparse meeting in terms of the number of new funding applications and funding applications for ...
Posted by Michael Wonder on 16 Nov 2021
PHARMAC widens access to adalimumab through transition to biosimilar
17 November 2021 - Pharmac’s chief medical officer Dr David Hughes has today announced the decision to fund a biosimilar adalimumab ...
Posted by Michael Wonder on 07 Nov 2021
COVID-19: PHARMAC confident with growing stock of drugs to treat virus
7 November 2021 - PHARMAC is growing increasingly confident it is getting close to having enough of the drugs needed to ...
Posted by Michael Wonder on 06 Nov 2021
PHARMAC to fund baricitinib to treat moderate to severe cases of COVID-19
5 November 2021 - PHARMAC has purchased another new medicine, baricitinib, to treat moderate to severe cases of COVID-19, with 500 ...
Posted by Michael Wonder on 04 Nov 2021
A breakthrough treatment for cystic fibrosis needs funding now
3 November 2021 - Let’s just kick this off by addressing the elephant in the room. Trikafta, the breakthrough treatment ...
Posted by Michael Wonder on 03 Nov 2021
Government makes a mockery of PHARMAC review
3 November 2021 - “The ACT Party can today reveal the review into PHARMAC has been delayed by more than ...
Posted by Michael Wonder on 03 Nov 2021
Major PHARMAC review delayed nearly 3 months
3 November 2021 - A major review into Government drug buying agency PHARMAC has been delayed by nearly three months. ...
Posted by Michael Wonder on 31 Oct 2021
New Zealand Pharmaceutical Schedule - November 2021 update
1 November 2021 - The November 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Oct 2021
PHARMAC negotiates deal for a further COVID-19 treatment
31 October 2021 - PHARMAC has negotiated an agreement with Roche to purchase another COVID-19 treatment. ...
Posted by Michael Wonder on 26 Oct 2021
Cystic fibrosis medicine added to PHARMAC's options for investment list
27 October 2021 - PHARMAC has announced that Vertex’s triple combination modulator therapy, known in some countries as Trikafta, has ...
Posted by Michael Wonder on 20 Oct 2021
PHARMAC says all patients who meet criteria will get next generation diabetes drugs, despite concerns
20 October 2021 - PHARMAC says it will fund next generation diabetes drugs for all people with the condition who ...
Posted by Michael Wonder on 20 Oct 2021
Bringing a consumer perspective to clinical advice
19 October 2021 - PHARMAC is making changes to the way its advisory committees work to strengthen the input of ...
Posted by Michael Wonder on 12 Oct 2021
Where is the PHARMAC Review Panel’s interim report?
12 October 2021 - Patient advocacy groups and clinicians are calling out the PHARMAC Review Panel for failing to get their ...